Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia

Neuropharmacology

Volumn 39, Issue 9, 2000, Pages 1637-1644

  Caporaso, Gregg L ^a,b   Bibb, James A ^a   Snyder, Gretchen L ^a   Valle, Carmina ^a   Rakhilin, Sergey ^a   Fienberg, Allen A ^a   Hemmings Jr , Hugh C ^a,b   Nairn, Angus C ^a   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cocaine; Cyclic AMP dependent protein kinase; Methamphetamine; Phosphoprotein; Phosphorylation state specific antibody; Protein phosphatase

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CALYCULIN A; COCAINE; CYCLOSPORIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; QUINPIROLE; RACLOPRIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPHOSPHORYLATION; DRUG ABUSE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BASAL GANGLIA; CATTLE; COCAINE; CORPUS STRIATUM; CYCLOSPORINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE UPTAKE INHIBITORS; ENZYME INHIBITORS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; OKADAIC ACID; OXAZOLES; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; STREET DRUGS;

EID: 0034029747     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00230-0     Document Type: Article

References (23)

1. Czernik A.J., Mathers J., Mische S.M. Phosphorylation state-specific antibodies. Hemmings H.C. Jr. Regulatory Protein Modification: Techniques and Protocols. 1997;219-250 Humana, Totowa, NJ.
2. Ehrlich M.E., Greengard P. Characterization of rat ARPP-21 mRNA: sequence analysis, tissue distribution, and regulation. Journal of Neurochemistry. 57:1991;1985-1991.
3. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W.J., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J.A., Nestler E.J., Greengard P. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science. 281:1998;838-842.
4. Garris P.A., Kilpatrick M., Bunin M.A., Michael D., Walker Q.D., Wightman R.M. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature. 398:1999;67-69.
5. Girault J.A., Shalaby I.A., Rosen N.L., Greengard P. Regulation by cAMP and vasoactive intestinal peptide of phosphorylation of specific proteins in striatal cells in culture. Proceedings of the National Academy of Science USA. 85:1988;7790-7794.
6. Greengard, P., Allen, P.B., Nairn, A.C., 1999. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447.
7. r=21,000) enriched in dopamine-innervated brain regions: amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro. Journal of Biological Chemistry. 264:1989;7726-7733.
8. Hemmings H.C. Jr., Greengard P. ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus. Journal of Neuroscience. 9:1989;851-864.
9. Hemmings H.C. Jr., Greengard P., Tung H.Y.L., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein-phosphatase-1. Nature. 310:1984;503-505.
10. Ishihara H., Martin B.L., Brautigan D.L., Karaki H., Ozaki H., Kato Y., Fusetani N., Watabe S., Hashimoto K., Uemara D., Hartshorne D.J. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochemistry and Biophysics Research Communications. 159:1989;871-877.
11. Kaczmarek K.L., Jennings K.R., Strumwasser F., Nairn A.C., Walter U., Wilson F.D., Greengard P. Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture. Proceedings of the National Academy of Science USA. 77:1980;7487-7491.
12. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
14. Levey A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik N.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., Ciliax B.J. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proceedings of the National Academy of Science USA. 90:1993;8861-8865.
15. Nishi A., Snyder G.L., Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. Journal of Neuroscience. 17:1997;8147-8155.
16. Ouimet C.C., Hemmings H.C. Jr., Greengard P. ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain. Journal of Neuroscience. 9:1989;865-875.
17. Robbins T.W., Everitt B.J. Drug addiction: bad habits add up. Nature. 398:1999;567-570.
18. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annual Review of Neuroscience. 18:1995;463-495.
19. Stoof J., Kebabian J. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 294:1981;366-368.
20. Towbin H., Staehlin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Science USA. 76:1979;4350-4354.
21. Tsou K., Girault J.-A., Greengard P. Dopamine D1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantial nigra. Journal of Neurochemistry. 60:1993;1043-1046.
22. Walaas S.I., Nairn A.C., Greengard P. Regional distribution of calcium- and cyclic adenosine 3′:5′-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems. Journal of Neuroscience. 3:1983;302-311.
23. Williams K.R., Hemmings H.C. Jr., LoPresti M.B., Greengard P. ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Amino acid sequence of ARPP-21B from bovine caudate nucleus. Journal of Neuroscience. 9:1995;3631-3637.